Delivery Order SPE2DB20D1100-SPE2DB25FY80F

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,066.74 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a medical product. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,886.47 firm fixed-price delivery order is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,222.80 firm-fixed-price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a medical product, with a performance period ending on March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $4,005.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RECOTHROM, a 20,000 unit vial pharmaceutical product, with a completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,139.43 Firm Fixed Price contract is for the delivery of 20,000 unit vials of the specialty medication RECOTHROM. This award is a Delivery Order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,528.69 firm fixed price contract is for the delivery of 20,000 unit vials of the medical product RECOTHROM. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RECOTHROM 20,000 unit spray kits. The Firm Fixed Price delivery order has a ceiling value of $1,775.28 and an ultimate completion date of October 16, 2024. This contract is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, will supply these critical medical products to support military...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FY63R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,775.28 Firm Fixed Price delivery order is for the supply of 20,000 units of RECOTHROM, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. There is no set-aside designation for this contract....
The federal contract award with ID SPE2DX15D1022|SPE2DX25FUZYU was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $5,802.30 firm fixed price delivery order is for the supply of 20,000 unit vials of RECOTHROM, a pharmaceutical product. This contract is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of RECOTHROM, a medical product, with a ceiling value of $1,136.94 and a completion date of June 5, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY80F
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,775.28 firm-fixed-price delivery order is for RECOTHROM 20,000 UNIT SPRAY KTS, with an ultimate completion date of October 31, 2024. The contract is not designated with a set-aside.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/29/25, 9:02 AM